Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Generic Copies of Remicade Go on Sale in Europe

wsj.com — Generic-drug makers have begun selling lower-priced copies of the blockbuster anti-inflammatory drug Remicade throughout Europe in recent days, a milestone in the emerging market for so-called "biosimilars," or generic versions of complex biotechnology drugs. An approaching wave of biosimilars in Europe and the U.S.

Painkiller in short supply following Hospira recall

marketwatch.com — A generic painkiller widely used in hospitals is in short supply after Hospira Inc. recalled more than 60 lots of vials due to contamination by crystal particles that could cause problems if injected into patients.

Painkiller in Short Supply Following Hospira Recall

wsj.com — A generic painkiller widely used in hospitals is in short supply after Hospira Inc. recalled more than 60 lots of vials due to contamination by crystal particles that could cause problems if injected into patients.

Florida Man Sentenced to Six Years for 2010 Prescription Drug Heist

wsj.com — A federal judge sentenced a Cuban citizen living in Florida to six years and three months in prison for his role in the brazen heist of an estimated $80 million worth of prescription drugs from an Eli Lilly & Co. warehouse in Connecticut in 2010, believed to be the largest pharmaceutical theft in U.S.

What to look for in Merck earnings

marketwatch.com — Merck & Co. (MRK) is scheduled to report its fourth-quarter 2014 financial results on Wednesday before the market opens. Here is what you need to know. Earnings: Analysts surveyed by Thomson Reuters expect earnings of 86 cents a share, excluding certain items, down from 88 cents a share a year earlier.

Chimerix Scraps Testing of Experimental Ebola Drug in Liberia

wsj.com — Chimerix Inc. scrapped testing of its experimental antiviral in Ebola patients in Liberia, saying the number of infections had dropped in recent weeks, and that only a handful of patients had been enrolled in the Liberian study.

States Work to Strike Deals for Hep C Drug Discounts

wsj.com — The battle for market share in the booming business for hepatitis C drugs is shifting to state Medicaid programs, which are busy negotiating discounts and supply deals with pharmaceutical companies. Missouri and Connecticut are among the states that are either negotiating or securing discounts on expensive new hepatitis C drugs in exchange for making them the preferred options for their state's Medicaid recipients.

Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the U.S.

blogs.wsj.com — Rival hepatitis C drugs from Merck and Vertex Pharmaceuticals made a big splash when they debuted in 2011, marking an advance in treatment of the liver disease and a lucrative new market segment. But now the Class of 2011 has almost sunk to the bottom, made obsolete by a newer wave of drugs, a sign of how rapidly the hepatitis C market is changing.

Study of Ebola Drug ZMapp Set for West Africa

wsj.com — A clinical trial of the experimental Ebola drug ZMapp may be ready to get under way in infected patients in West Africa in February, the latest effort to combat the current epidemic and any future outbreaks.

Merck Accelerates Drug-Submission Plans

wsj.com — Merck & Co. has accelerated its plans to submit new drugs for hepatitis C and lung cancer for regulatory approval, in a bid to close the gap with competitors in two lucrative segments. The Kenilworth, N.J., drug maker hopes that an overhaul of its research-and-development engine in the past 18 months has positioned it to introduce the new drugs at least several months earlier than expected.
More Articles →
Feb 27, 2015

FDA finds problems at Hospira plant in India, no problems at Costa Rica plant $HSP $PFE sec.gov/Archives/edgar…

Feb 27, 2015

RT @jonathanrockoff: Former $SNY CEO Viehbacher joins Robert Langer, @daphnezohar & colleagues at PureTech, becoming BoD member: http://t.c…

Feb 27, 2015

Nice work @ObserverNDSMC MT @romenesko Hesburgh died late last night, ND student paper gets it in print edition: bit.ly/1MYRpGm

Feb 27, 2015

Novartis amends heart-drug trial to explore potential Alzheimer's link: on.wsj.com/17BZaRX via @WSJ @pharmalot $NVS

Feb 26, 2015

RT @jon_kamp: Biggest U.S. health insurer tightens rules on hysterectomy coverage in wake of #morcellator debate on.wsj.com/1C1eXa4 via @WSJ

Feb 26, 2015

RT @matthewherper: Read this piece, by the NY doctor who had Ebola, if you haven't. Important. nejm.org/doi/full/10.10…

Feb 26, 2015

RT @JeanneWhalen: Andrew Witty gets 46% pay cut after tough year at $GSK (but still earns considerably more than I do...) on.wsj.com/1wsAYx4 by @pharmalot

Feb 26, 2015

CDC panel today also added Merck's new Gardasil 9 as option for routine HPV vaccination of adolescents. $MRK $GSK

Feb 26, 2015

RT @MarkianHawryluk: University of Oregon in midst of outbreak MT @Loftus: CDC panel: students at colleges with meningitis B outbreaks should get new vaccine



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.


Share This Profile